Poolbeg Pharma secures backing from major investor in merger target
News Source : The Irish Times
News Summary
- Poolbeg announced last week that it is in early talks with Hookipa
- An all-share deal – being engineered as a reverse takeover – would see Poolbeg investors initially take a 55 per cent stake in the merged entity
- A planned $30 million equity raise immediately after the tie-up would dilute the stakes of legacy investors in both
A plan by Poolbeg Pharma, the clinicalstage biopharmaceutical company led by serial entrepreneur Cathal Friel, to merge with Nasdaqlisted peer Hookipa Pharma has secured backing from a major shareh [+1812 chars]
Never miss a story from us, subscribe to our newsletter